Skip to main content
DNA Labs India

Parkinson Disease Panel NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

Parkinson Disease Panel NGS Genetic Test

Short Name: PD NGS Panel

Also known as: Parkinson's Disease Genetic Panel, Parkinson Disease NGS Panel, Hereditary Parkinsonism Panel

Parkinson Disease Panel NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood / Extracted DNA / FTA Card blood spot samples. Results in Results are generally issued within 3 to 4 weeks of sample reaching the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll ages (commonly adults)🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to examine patient DNA for mutations in genes known to be associated with Parkinson disease. NGS technology allows simultaneous analysis of multiple genes from a single blood sample. The test may help identify an inherited cause in suspected hereditary parkinsonism and provide a basis for genetic counseling of family members.

Test Code
3861
ICD Code
G20
Price
₹20,000
Sample Type
Blood / Extracted DNA / FTA Card blood spot
Result Time
Results are generally issued within 3 to 4 weeks of sample reaching the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. Please provide the referring physician's clinical details and any relevant family history. A genetic counselling session is recommended before the test to prepare a pedigree chart and confirm the appropriate panel.

Method: Peripheral venous blood draw or FTA card blood spot

Step 2

Laboratory Analysis

A trained phlebotomist will collect a venous blood sample from the arm. If using an FTA card, one or more drops of blood will be placed on the card and allowed to dry. The procedure is quick and performed under sterile conditions.

Step 3

Report Delivery

You may resume all routine activities immediately after sample collection. The sample is labelled and transported to the laboratory under controlled conditions. The report will be shared through the chosen method once available.

Timeline: Results are generally issued within 3 to 4 weeks of sample reaching the laboratory.

Patient Instructions

1
Before the Test:Before the test, the doctor will review the patient's history, motor symptoms, and family tree. Genetic counselling is recommended so that the patient understands the scope, risks, benefits and possible outcomes of the NGS test.
2
During the Test:The test involves collection of a blood sample or FTA card spot. No special medication changes or fasting are required. If additional samples are needed, the lab team will inform the patient.
3
After the Test:After testing, the laboratory performs NGS analysis, data processing, variant annotation, and clinical interpretation. The report is delivered in 3 to 4 weeks. It includes the interpreted clinical report and raw FASTQ and VCF data as applicable.

About This Test

Who Should Get This Test

The purpose of this test is to examine patient DNA for mutations in genes known to be associated with Parkinson disease. NGS technology allows simultaneous analysis of multiple genes from a single blood sample. The test may help identify an inherited cause in suspected hereditary parkinsonism and provide a basis for genetic counseling of family members.

How to Prepare

  • No fasting required
  • Use EDTA tube for whole blood collection
  • FTA card should be dried and stored in a protective pouch
  • Label the sample with patient name, UID and date of collection
  • If sending extracted DNA, store and ship in a DNA stabilization tube

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"A targeted NGS panel can be valuable when the clinical picture suggests an inherited form of Parkinson disease. However, the result should always be interpreted alongside the neurological examination, disease duration, and family history."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood / Extracted DNA / FTA Card blood spot
Sample VolumeAs required for NGS laboratory protocol
ContainerEDTA vacutainer / FTA card / DNA elution tube
Collection MethodPeripheral venous blood draw or FTA card blood spot

Sample Stability

Whole blood in EDTA: stable for 72 hours at 2-8°C
FTA card blood spot: stable at room temperature for several weeks if kept dry
Extracted DNA: stable for months at -20°C or below
Sample Rejection Criteria:
  • Clotted or hemolyzed blood
  • Incorrect or missing patient identification
  • Insufficient blood amount / DNA concentration
  • Sample leaking or broken in transit
  • FTA card that is wet, mouldy, or contaminated

Understanding Your Results

The clinical report should be read by the referring neurologist or clinical geneticist. Variants are classified using established ACMG guidelines. The presence or absence of a genetic variant must always be correlated with the patient's clinical examination and family pedigree.
📊

Suggests a genetic/targeted diagnosis for hereditary Parkinson disease. Consult a neurologist and genetic counselor for clinical correlation and family member testing.

📊

A variant was found, but its clinical significance is not yet established. Additional segregation or functional studies may help clarify the result.

📊

No clinically significant variants were found in the genes analyzed. This does not exclude Parkinson disease due to non-genetic causes or genes not covered by this panel.

⚠️ When to Consult a Doctor:

Consult a neurologist or genetic counselor if the test report shows a pathogenic/likely pathogenic variant, a VUS, or if the result may affect family members. Do not make treatment decisions solely based on this genetic test.

Limitations

  • A negative result does not exclude a diagnosis of Parkinson disease.
  • A positive result does not predict with certainty whether or when symptoms will appear.
  • The test only covers genes included in the panel; mutations in other genes will not be detected.
  • Variants of uncertain significance may be reported and require further family studies.
  • This test is not a substitute for a clinical neurological examination.

Risks & Considerations

  • Slight pain or bruising at the blood collection site
  • Dizziness on rare occasions
  • Very low risk of local infection
  • No radiation or contrast-agent risk

Interfering Factors

  • Low-quality or degraded DNA may affect sequencing accuracy.
  • Insufficient DNA quantity can lead to partial results.
  • Variants in intronic or regulatory regions not covered by the panel may be missed.
  • Large copy-number variants and repeat expansions may not be reliably detected by standard NGS.
  • Sample contamination with another individual's DNA can alter results.

Compare With Similar Tests

TestParkinson Disease Panel NGS Genetic TestParkinson Disease NGS PanelSingle-Gene Targeted TestWhole Exome Sequencing
ComparisonParkinson Disease Panel NGS Genetic Test

Frequently Asked Questions

What is the Parkinson Disease Panel NGS Genetic Test?
It is a next-generation sequencing based genetic test that analyzes genes associated with Parkinson disease and related parkinsonian disorders. It helps identify inherited genetic variants that may contribute to disease development.
Who should consider this test?
People with early-onset Parkinson disease, a significant family history of Parkinson disease, atypical features, or those requiring genetic counseling may consider this test. A neurologist or geneticist should advise the appropriate clinical indication.
Is fasting required before the test?
No. The test can be performed without fasting, at any time of the day.
What sample is needed for this test?
Whole blood in an EDTA tube, a single blood spot on FTA card, or extracted DNA can be used for this test.
How long does it take to get results?
Reports are generally available in 3 to 4 weeks after the sample reaches the laboratory.
Which genes are included in the panel?
The panel includes genes such as SNCA, LRRK2, GBA, PRKN, PINK1, PARK7, VPS35 and ATP13A2, among others, depending on laboratory panel design.
Can this test alone diagnose Parkinson disease?
No. Parkinson disease is diagnosed clinically by a neurologist. Genetic testing provides supportive information and helps identify hereditary forms, but a positive result does not automatically mean disease onset, and a negative result does not rule out Parkinson disease.
What does a positive result mean?
A pathogenic or likely pathogenic variant was found. This suggests an increased likelihood or genetic cause for Parkinson disease, but clinical correlation, family history, and genetic counseling are essential.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic change whose effect on disease is not yet clear. It is not counted as a positive or negative result; further family studies or research may be needed.
Why should I ask for raw data, FASTQ and VCF files?
These files allow the patient or a second genetics team to re-analyze the data, reinterpret variants, and maintain data transparency. DNA Labs India provides raw data along with the clinical report.
What is the cost of this test in India?
The displayed cost is Rs 20,000 including free home sample collection in select cities. Actual billing may include counseling charges if separately recommended.
Will insurance cover this test?
Usually not as a routine test. PMJAY, CGHS, ECHS and ESIC coverage is not guaranteed; private insurance may cover based on policy and medical necessity. Please check with the insurer before scheduling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.